A Phase 1/2 Trial of Selinexor (KPT-330) and Radiation Therapy in Newly-Diagnosed Pediatric Diffuse Intrinsic Pontine Glioma (DIPG) and High-Grade Glioma (HGG)
Latest Information Update: 09 Sep 2024
At a glance
- Drugs Selinexor (Primary)
- Indications Diffuse intrinsic pontine glioma; Glioma
- Focus Adverse reactions; Therapeutic Use
- 08 May 2024 Status changed from suspended to recruiting.
- 07 Mar 2024 Status changed from recruiting to suspended (due to transition of Pre-Screening (Step 0) process ).
- 02 Jun 2023 Planned End Date changed from 30 Jun 2024 to 30 Jun 2027.